Twelve-month outcomes of treatment using ranibizumab or aflibercept for neovascular age-related macular degeneration: a comparative study
Crossref DOI link: https://doi.org/10.1007/s00417-016-3353-7
Published Online: 2016-05-26
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Jae Hui
Lee, Dong Won
Chang, Young Suk
Kim, Jong Woo
Kim, Chul Gu
Text and Data Mining valid from 2016-05-26